U
Premier Biomedical, Inc.
BIEI
$0.0006
$0.000.00%
D
Sell
11/9/2020Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 11/9/2020 due to an increase in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 11/9/2020 due to an increase in the volatility index and total return index.
D
Sell
10/22/2020Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 10/22/2020 due to a decline in the volatility index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 10/22/2020 due to a decline in the volatility index.
D
Sell
10/2/2020Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 10/2/2020 due to an increase in the volatility index.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 10/2/2020 due to an increase in the volatility index.
D
Sell
9/17/2020Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 9/17/2020 due to a decline in the volatility index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 9/17/2020 due to a decline in the volatility index.
D
Sell
8/27/2020Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 8/27/2020 due to an increase in the volatility index.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 8/27/2020 due to an increase in the volatility index.
D
Sell
8/12/2020Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 8/12/2020 due to a decline in the volatility index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 8/12/2020 due to a decline in the volatility index.
D
Sell
7/23/2020Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 7/23/2020 due to an increase in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 7/23/2020 due to an increase in the volatility index and total return index.
D
Sell
7/8/2020Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 7/8/2020 due to a decline in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 7/8/2020 due to a decline in the volatility index and total return index.
D
Sell
6/17/2020Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 6/17/2020 due to an increase in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 6/17/2020 due to an increase in the volatility index and total return index.
D
Sell
6/2/2020Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 6/2/2020 due to a decline in the volatility index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 6/2/2020 due to a decline in the volatility index.
D
Sell
5/15/2020Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 5/15/2020 due to an increase in the volatility index and solvency index.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 5/15/2020 due to an increase in the volatility index and solvency index.
D
Sell
5/4/2020Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 5/4/2020 due to a significant decline in the efficiency index and solvency index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 5/4/2020 due to a significant decline in the efficiency index and solvency index.
D
Sell
11/15/2019Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 11/15/2019 due to a significant increase in the efficiency index, valuation index and growth index. Earnings per share increased from -$0.0223 to -$0.01, net income increased 20% from -$227 to -$181.6, and EBIT increased 11.39% from -$72.9 to -$64.6.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 11/15/2019 due to a significant increase in the efficiency index, valuation index and growth index. Earnings per share increased from -$0.0223 to -$0.01, net income increased 20% from -$227 to -$181.6, and EBIT increased 11.39% from -$72.9 to -$64.6.
D
Sell
5/17/2019Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 5/17/2019 due to a significant decline in the efficiency index and total return index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 5/17/2019 due to a significant decline in the efficiency index and total return index.
D
Sell
11/27/2018Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from E+ on 11/27/2018 due to a significant increase in the efficiency index.
Premier Biomedical, Inc. (BIEI) was upgraded to D from E+ on 11/27/2018 due to a significant increase in the efficiency index.
E
Sell
7/12/2018Downgrade
Premier Biomedical, Inc. (BIEID) was downgraded to E+ from D- on 7/12/2018 due to a decline in the volatility index and total return index.
Premier Biomedical, Inc. (BIEID) was downgraded to E+ from D- on 7/12/2018 due to a decline in the volatility index and total return index.
D
Sell
6/27/2018Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D- from E+ on 6/27/2018 due to an increase in the volatility index.
Premier Biomedical, Inc. (BIEI) was upgraded to D- from E+ on 6/27/2018 due to an increase in the volatility index.
E
Sell
5/24/2018Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to E+ from D on 5/24/2018 due to a significant decline in the efficiency index.
Premier Biomedical, Inc. (BIEI) was downgraded to E+ from D on 5/24/2018 due to a significant decline in the efficiency index.
D
Sell
1/3/2018Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 1/3/2018 due to a decline in the total return index, volatility index and growth index. EBIT declined 168.22% from -$85.9 to -$230.4.
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 1/3/2018 due to a decline in the total return index, volatility index and growth index. EBIT declined 168.22% from -$85.9 to -$230.4.
D
Sell
8/15/2017Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 8/15/2017 due to an increase in the total return index.
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 8/15/2017 due to an increase in the total return index.
D
Sell
7/21/2017Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 7/21/2017 due to a decline in the volatility index.
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 7/21/2017 due to a decline in the volatility index.
D
Sell
6/30/2017Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 6/30/2017 due to an increase in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 6/30/2017 due to an increase in the volatility index and total return index.
D
Sell
6/15/2017Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 6/15/2017 due to a decline in the volatility index, total return index and solvency index. Debt to equity increased from -0.28 to -0.01.
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 6/15/2017 due to a decline in the volatility index, total return index and solvency index. Debt to equity increased from -0.28 to -0.01.
D
Sell
5/10/2017Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 5/10/2017 due to a significant increase in the efficiency index, growth index and total return index. Earnings per share increased from -$0.0026 to -$0.0008, net income increased 55% from -$435.1 to -$195.8, and EBIT increased 27.51% from -$151.2 to -$109.6.
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 5/10/2017 due to a significant increase in the efficiency index, growth index and total return index. Earnings per share increased from -$0.0026 to -$0.0008, net income increased 55% from -$435.1 to -$195.8, and EBIT increased 27.51% from -$151.2 to -$109.6.
D
Sell
1/12/2017Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 1/12/2017 due to an increase in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 1/12/2017 due to an increase in the volatility index and total return index.
D
Sell
12/28/2016Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 12/28/2016 due to a decline in the total return index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 12/28/2016 due to a decline in the total return index.
D
Sell
11/18/2016Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 11/18/2016 due to an increase in the total return index and growth index. Earnings per share increased from -$0.0062 to -$0.0026, EBIT increased 15.53% from -$179 to -$151.2, and operating cash flow increased 6.82% from -$85.1 to -$79.3.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 11/18/2016 due to an increase in the total return index and growth index. Earnings per share increased from -$0.0062 to -$0.0026, EBIT increased 15.53% from -$179 to -$151.2, and operating cash flow increased 6.82% from -$85.1 to -$79.3.
D
Sell
9/26/2016Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 9/26/2016 due to a decline in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 9/26/2016 due to a decline in the volatility index and total return index.
D
Sell
8/26/2016Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 8/26/2016 due to an increase in the growth index. Operating cash flow increased 64.35% from -$238.7 to -$85.1, and EBIT increased 9.64% from -$198.1 to -$179.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 8/26/2016 due to an increase in the growth index. Operating cash flow increased 64.35% from -$238.7 to -$85.1, and EBIT increased 9.64% from -$198.1 to -$179.
D
Sell
8/8/2016Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 8/8/2016 due to a decline in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 8/8/2016 due to a decline in the volatility index and total return index.
D
Sell
6/16/2016Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 6/16/2016 due to an increase in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 6/16/2016 due to an increase in the volatility index and total return index.
D
Sell
5/18/2016Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 5/18/2016 due to a significant decline in the efficiency index. Net income declined 119.17% from -$189.4 to -$415.1.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 5/18/2016 due to a significant decline in the efficiency index. Net income declined 119.17% from -$189.4 to -$415.1.
D
Sell
4/1/2016Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 4/1/2016 due to a significant increase in the efficiency index. Total capital increased 31.79% from -$266.4 to -$181.7.
Premier Biomedical, Inc. (BIEI) was upgraded to D from D- on 4/1/2016 due to a significant increase in the efficiency index. Total capital increased 31.79% from -$266.4 to -$181.7.
D
Sell
3/11/2016Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index and total return index.
Premier Biomedical, Inc. (BIEI) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index and total return index.
D
Sell
1/15/2016Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 1/15/2016 due to a noticeable decline in the total return index and volatility index.
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 1/15/2016 due to a noticeable decline in the total return index and volatility index.
D
Sell
12/31/2015Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 12/31/2015 due to a noticeable increase in the total return index and volatility index.
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 12/31/2015 due to a noticeable increase in the total return index and volatility index.
D
Sell
11/17/2015Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D from C- on 11/17/2015 due to a substantial decline in the valuation index.
Premier Biomedical, Inc. (BIEI) was downgraded to D from C- on 11/17/2015 due to a substantial decline in the valuation index.
C
Hold
10/28/2015Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to C- from D on 10/28/2015 due to a substantial increase in the valuation index and growth index.
Premier Biomedical, Inc. (BIEI) was upgraded to C- from D on 10/28/2015 due to a substantial increase in the valuation index and growth index.
D
Sell
5/15/2015Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D from C- on 5/15/2015 due to a significant decline in the efficiency index, growth index and solvency index. Debt to equity increased from -0.22 to -0.48, and the quick ratio declined from 0.54 to 0.27.
Premier Biomedical, Inc. (BIEI) was downgraded to D from C- on 5/15/2015 due to a significant decline in the efficiency index, growth index and solvency index. Debt to equity increased from -0.22 to -0.48, and the quick ratio declined from 0.54 to 0.27.
C
Hold
4/2/2015Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to C- from D on 4/2/2015 due to a significant increase in the efficiency index, solvency index and growth index. Earnings per share increased from -$0.0119 to -$0.0314, net income increased 161.66% from -$247 to -$646.3, and EBIT increased 156.76% from -$247 to -$634.2.
Premier Biomedical, Inc. (BIEI) was upgraded to C- from D on 4/2/2015 due to a significant increase in the efficiency index, solvency index and growth index. Earnings per share increased from -$0.0119 to -$0.0314, net income increased 161.66% from -$247 to -$646.3, and EBIT increased 156.76% from -$247 to -$634.2.
D
Sell
4/2/2014Downgrade
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 4/2/2014 due to a significant decline in the efficiency index, growth index and solvency index. Debt to equity increased from -0.16 to -0.44, the quick ratio declined from 0.41 to 0.06, and EBIT declined 40.91% from -$1.03M to -$605.8.
Premier Biomedical, Inc. (BIEI) was downgraded to D from D+ on 4/2/2014 due to a significant decline in the efficiency index, growth index and solvency index. Debt to equity increased from -0.16 to -0.44, the quick ratio declined from 0.41 to 0.06, and EBIT declined 40.91% from -$1.03M to -$605.8.
D
Sell
3/3/2014Upgraded
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 3/3/2014 due to a significant increase in efficiency, valuation and total return. Net income increased 384.44% from -$213.3 to -$1.03M.
Premier Biomedical, Inc. (BIEI) was upgraded to D+ from D on 3/3/2014 due to a significant increase in efficiency, valuation and total return. Net income increased 384.44% from -$213.3 to -$1.03M.
OTC PK
03/06/2025 11:16AM Eastern
Quotes delayed
